IPO registrations (S-1, F-1) · Registrants
ORAMED PHARMACEUTICALS INC.
- SEC CIK
- 1176309 · filings on EDGAR ↗
- Former names
- Integrated Security Technologies, Inc. (2004–2006); IGUANA VENTURES LTD (2002–2004)
- Registration
- Form S-1, first filed 2010-01-11, last 2013-02-01; 5 initial registrations, 2 amendments
- Outcome
- Declared effective 2010-01-12; withdrawal requested 2010-08-31
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, New York, NY 10036
- EIN
- 98-0376008
- Ticker
- ORMP (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- ORAMED PHARMACEUTICALS INC. on the corporate pages
Offering terms
- Shares offered
- 3,563,965
- Listing
- OTCQB under the symbol ORMP
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ORAMED PHARMACEUTICALS INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: ORAMED PHARMACEUTICALS INC. Fuzzy (name and state)
- Form D issuer: ORAMED PHARMACEUTICALS INC. EXACT (CIK (EXACT))
- SEC filer: Integrated Security Technologies, Inc. EXACT (CIK (EXACT))
Filings 18
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-01-11 | S-1 | S-1 (registration) | ORAMED PHARMACEUTICALS INC. | 0001144204-10-001314 ↗ |
| 2010-01-11 | S-1 | S-1 (registration) | ORAMED PHARMACEUTICALS INC. | 0001144204-10-001332 ↗ |
| 2010-01-12 | EFFECT | EFFECT (declared effective) | ORAMED PHARMACEUTICALS INC. | 9999999995-10-000185 ↗ |
| 2010-02-24 | S-1/A | S-1/A (amendment) | ORAMED PHARMACEUTICALS INC. | 0001144204-10-009726 ↗ |
| 2010-03-03 | EFFECT | EFFECT (declared effective) | ORAMED PHARMACEUTICALS INC. | 9999999995-10-000654 ↗ |
| 2010-08-31 | RW | RW (withdrawal request) | ORAMED PHARMACEUTICALS INC. | 0001144204-10-047441 ↗ |
| 2010-09-15 | EFFECT | EFFECT (declared effective) | ORAMED PHARMACEUTICALS INC. | 9999999995-10-002698 ↗ |
| 2011-03-25 | S-1 | S-1 (registration) | ORAMED PHARMACEUTICALS INC. | 0001144204-11-016974 ↗ |
| 2011-04-07 | S-1/A | S-1/A (amendment) | ORAMED PHARMACEUTICALS INC. | 0001144204-11-020722 ↗ |
| 2011-04-11 | EFFECT | EFFECT (declared effective) | ORAMED PHARMACEUTICALS INC. | 9999999995-11-000984 ↗ |
| 2011-06-29 | S-1 | S-1 (registration) | ORAMED PHARMACEUTICALS INC. | 0001178913-11-001827 ↗ |
| 2011-07-11 | EFFECT | EFFECT (declared effective) | ORAMED PHARMACEUTICALS INC. | 9999999995-11-002096 ↗ |
| 2012-02-24 | EFFECT | EFFECT (declared effective) | ORAMED PHARMACEUTICALS INC. | 9999999995-12-000561 ↗ |
| 2013-02-01 | S-1 | S-1 (registration) | ORAMED PHARMACEUTICALS INC. | 0001178913-13-000211 ↗ |
| 2013-02-12 | EFFECT | EFFECT (declared effective) | ORAMED PHARMACEUTICALS INC. | 9999999995-13-000472 ↗ |
| 2013-03-22 | EFFECT | EFFECT (declared effective) | ORAMED PHARMACEUTICALS INC. | 9999999995-13-000781 ↗ |
| 2013-08-22 | EFFECT | EFFECT (declared effective) | ORAMED PHARMACEUTICALS INC. | 9999999995-13-002484 ↗ |
| 2014-04-10 | EFFECT | EFFECT (declared effective) | ORAMED PHARMACEUTICALS INC. | 9999999995-14-000945 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-02-01 | S-1 | registration statement | $4.59 | 3,563,965 | $16,358,599 | OTCQB ORMP | 0 | primary document; price line, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bronfeld Zeev | TenPercentOwner | 4 | 2006–2011 | ||
| KIDRON NADAV | Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwner | CEO; President and CEO; President & CEO | 42 | 2006–2026 | |
| DRAZENOVIC GEORGE | Director,Officer | CFO, Secretary & Treasurer | 1 | 2006 | |
| WEBER ALEX | Officer | Treasurer & CFO | 2 | 2007 | |
| Kidron Miriam | Director; Director,Officer; Officer | Chief Medical &Tech Officer; Chief Scientific Officer; Chief Technology Officer; Chief Technology Officer; See Remarks | 38 | 2007–2026 | |
| Sank Leonard | Director | 28 | 2007–2025 | ||
| ORLEV CHAIME | Officer | CFO, Treasurer and Secretary; CFO, TREASURER AND SECRETARY | 3 | 2008–2009 | |
| JACOB HAROLD | Director | 11 | 2008–2016 | ||
| Zommer Yifat Hen | Officer; Officer,TenPercentOwner | CFO; CFO, Treasurer and Secretary; CFO, TREASURER AND SECRETARY | 6 | 2009–2017 | |
| Berelowitz Michael | Director | 9 | 2010–2015 | ||
| REGALS CAPITAL MANAGEMENT LP | TenPercentOwner | 10 | 2012–2015 | ||
| Regals Fund LP | TenPercentOwner | 8 | 2012–2015 | ||
| Slager David Mark | Director; Director,TenPercentOwner; TenPercentOwner | 14 | 2012–2019 | ||
| OSTROV GERALD M | Director | 5 | 2012–2015 | ||
| Hexter Joshua | Officer | Chf. Op. & Bus. Officer; Chief Operating & BO; Chief Operating Officer; COO, Business Officer; COO & CBO | 22 | 2013–2026 | |
| Li Xiaopeng | Director | 6 | 2016–2017 | ||
| Friedman Aviad | Director | 7 | 2016–2022 | ||
| RAKIN KEVIN | Director | 18 | 2016–2022 | ||
| Law Ronald Edward | Officer | Chief Strategy Officer | 2 | 2017 | |
| Eisenberg Hilla | Officer | CFO, Treasurer and Secretary | 3 | 2017–2019 | |
| Hasleton Mark Daniel | Officer | VP Business Development | 2 | 2018–2019 | |
| Gabay Avraham | Officer | CFO, Treasurer and Secretary; Chief Financial Officer | 14 | 2019–2026 | |
| Xiaoming Gao | Director | 2 | 2019–2020 | ||
| Mayer Arie | Director | 11 | 2019–2026 | ||
| Silberman David | Officer | Chief Financial Officer | 7 | 2021–2024 | |
| Rabinowitz Michael | Officer | Chief Commercial Officer | 3 | 2021–2023 | |
| Rabinowitz Michael | Officer | Chief Commercial Officer | 3 | 2021–2022 | |
| Derovan Netanel | Officer | Chief Legal Officer | 5 | 2022–2023 | |
| Rozov Yadin | Director | 6 | 2022–2024 | ||
| Shapiro Benjamin | Director | 5 | 2023–2026 | ||
| Aghion Daniel | Director | 5 | 2024–2026 | ||
| Reznick Yehuda | Director | 5 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2014-11-14 | ORAMED PHARMACEUTICALS INC. | Pharmaceuticals | $5,000,000 | $0 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ORAMED PHARMACEUTICALS INC. | NY | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | ORAMED PHARMACEUTICALS INC. | NY | State business registries | name and state |
| Form D issuer | ORAMED PHARMACEUTICALS INC. | Form D private offerings | CIK (EXACT) | |
| SEC filer | ORAMED PHARMACEUTICALS INC. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NY first:
- TG THERAPEUTICS, INC. NY
- SIGA TECHNOLOGIES INC NY
- SEELOS THERAPEUTICS, INC. NY
- Protagenic Therapeutics, Inc.\new NY
- XTL BIOPHARMACEUTICALS LTD NY
- PENWEST PHARMACEUTICALS CO NY
- CHEMBIO DIAGNOSTICS, INC. NY
- EYETECH PHARMACEUTICALS INC NY
- INNOVATIVE DRUG DELIVERY SYSTEMS INC NY
- EON LABS INC NY
In other datasets, the same topic (Health) in NY:
- Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health